BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX)

Historical Holders from Q4 2024 to Q3 2025

Symbol
BLRX on Nasdaq
Type / Class
Equity / Ordinary Shares, par value NIS 0.10 per share
Shares outstanding
2,402,091,667
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
27,595
Holdings value
$104,308
% of all portfolios
0%
Number of holders
13
Number of buys
4
Number of sells
9
Average buys %
0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 7.2% $632,999,196 172,950,600 Highbridge Capital Management, LLC 30 Jun 2025
As of 30 Sep 2025 BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 27,595 shares of 2,402,091,667 outstanding shares and own 0% of the company stock as of 30 Sep 2025.

Top 23 institutional shareholders of BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) own 0% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
CITADEL ADVISORS LLC 0% $37,876 10,020 -33%
UBS Group AG 0% $24,143 6,387
MORGAN STANLEY 0% $22,503 5,953 +286%
RHUMBLINE ADVISERS 0% $11,602 3,070 -28%
WELLS FARGO & COMPANY/MN 0% $6,615 1,750 0%
Nemes Rush Group LLC 0% $945 250 0%
NewEdge Advisors, LLC 0% $405 107 0%
Tower Research Capital LLC (TRC) 0% $147 39
Rockefeller Capital Management L.P. 0% $45 12
BANK OF AMERICA CORP /DE/ 0% $8 2 0%
SBI Securities Co., Ltd. 0% $8 2 0%
DANSKE BANK A/S 0% $8 2 0%
OSAIC HOLDINGS, INC. 0% $3 1 0%
NATIONAL BANK OF CANADA /FI/ 0% $0 0 -100%
SIMPLEX TRADING, LLC 0% $0 0 -100%
FIFTH THIRD BANCORP 0% $0 0 -100%
RAYMOND JAMES FINANCIAL INC 0% $0 0 -100%
CITIGROUP INC 0% $0 0 -100%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0% $0 0 -100%
TWO SIGMA SECURITIES, LLC 0% $0 0 -100%
CITADEL ADVISORS LLC 0% $0 0 -100%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0% $76,356 20,200
CITADEL ADVISORS LLC 0% $0 0 -100%

Institutional Holders of BioLineRx Ltd. - Ordinary Shares, par value NIS 0.10 per share (BLRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 27,595 $104,308 -$179,717 $3.78 13
2025 Q2 66,216 $302,103 +$267,703 $4.57 17
2025 Q1 9,458 $27,991 +$18,523 $2.96 11
2024 Q4 20,064 $4,294 +$4,294 $0.2140 1